Genetic aspects of central hypothyroidism

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology

Background:

• Central hypothyroidism is a rare endocrine disorder characterized by inadequate thyroid-stimulating hormone (TSH) secretion, leading to low thyroid hormone levels.
• While often caused by pituitary tumors or atrophy, genetic factors are increasingly recognized as a cause of central hypothyroidism.
• These genetic defects provide insights into the normal functioning and disease mechanisms of the hypothalamo-pituitary-thyroid axis (HPTA).

Purpose of the Study:

• To review and analyze reported genetic mutations affecting the HPTA.
• To understand how these mutations lead to central hypothyroidism and combined pituitary hormone deficiency (CPHD).
• To elucidate the physiological and pathophysiological roles of affected genes in the HPTA.

Main Methods:

• Literature review of studies reporting mutations in genes regulating the HPTA.
• Analysis of genetic defects causing isolated central hypothyroidism or CPHD.
• Focus on mutations in genes encoding the TRH receptor, Pit-1, PROP1, and TSH beta-subunit.

Main Results:

• Inactivating mutations in several genes crucial for HPTA regulation have been identified.
• These mutations can result in either isolated central hypothyroidism or CPHD.
• Specific genes implicated include those for the TRH receptor, Pit-1, PROP1, and the TSH beta-subunit.

Conclusions:

• Genetic mutations are a significant cause of central hypothyroidism and CPHD.
• Studying these genetic defects advances our understanding of HPTA physiology and pathophysiology.
• Further research into these genetic underpinnings is essential for diagnosis and potential therapeutic strategies.